New use of a combination of sacubitril and valsartan
AssigneeNovartis AG
InventorsFabian Chen, Surya Prakash Ayalasomayajula, Christopher Bush, Masha Berkhin, Gesine Winzenburg, Bernd Trueby
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and pharmaceutical compositions for treating heart failure in a pediatric human patient comprising administration to said patient of a therapeutically effective amount or a prophylactically effective amount of a combination of a therapeutic agent blocking the angiotensin receptor and a therapeutic agent inhibiting the NEP enzyme, in particular of a combination of sacubitril and valsartan in a pharmaceutically acceptable form and in a 1:1 molar ratio.
Claims20
A method for the prevention or treatment of heart failure in a human pediatric patient in need of such prevention or treatment comprising administering to said patient a therapeutically effective amount or a prophylactically effective amount of a combination of sacubitril and valsartan in a 1:1 molar ratio.
Dependencies are inferred from the claim text.